Appeals Court Rebuffs Bankman-Fried’s Bid for New Trial
A three-judge panel affirmed the 25-year sentence for Sam Bankman-Fried in the FTX fraud case and denied his bid for ...
Explore various ways to find money for debt repayment. Take charge of your finances today and start your journey towards being debt-free!
16,741 articlesA three-judge panel affirmed the 25-year sentence for Sam Bankman-Fried in the FTX fraud case and denied his bid for ...
Oil’s 5.7% weekly drop is fueling a rotation into jet, materials, and infrastructure plays as traders reassess fuel c...
Two defense-focused ETFs offer distinct paths to play defense spending. This guide compares SHLD and ITA on cost, hol...
After years of policy shifts and supply hiccups, a clearer EV roadmap is starting to emerge. This analysis explains w...
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Roughly 1 in 10 Medicare Advantage enrollees will lose their current plan for 2026 as insurers retreat from markets. ...
A high-yield AI-focused ETF sounds tempting, but a big payout can hide risks. This article breaks down how the divide...
The week brought a roughly 10% drop for Xanadu Quantum Technologies stock as market enthusiasm cools and insiders tra...
A big wave of Iranian crude has hit global markets after Washington opened waivers, potentially adding 130-150 millio...
Palantir CEO Alex Karp argues that token-based access to frontier AI models is eroding enterprise value. The remarks ...
Vanguard’s $143 billion tech ETF has outpaced the Nasdaq-100 tracker this year, riding a cost advantage and AI-driven...
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...